Scientific Evidence

We are presenting at the 2024 American Thyroid Association Annual Meeting - Chicago, IL October 30 - November 3, 2024 - Come see us!

Abstract: RAI GuidePx: A robust predictor for radioactive iodine sensitivity status in papillary thyroid cancer leveraging thyroid differentiation genes.

Abstract: Molecular subtypes in radiation induced papillary thyroid cancer using Thyroid GuidePx.

A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023]

Improved Risk Stratification for Papillary Thyroid Cancer (PTC) using a genomic classifier informed by clinical features [2022]

Molecular subgroups identified by machine learning enable accurate prognostication of papillary thyroid cancer [2021]

Abstract: RAI GuidePx: A robust predictor for radioactive iodine sensitivity status in papillary thyroid cancer leveraging thyroid differentiation genes.

Abstract: Molecular subtypes in radiation induced papillary thyroid cancer using Thyroid GuidePx.

The Technological Drivers Powering Precision Oncology

Unique Thyroid Cancer Tests: New Hope Unveiled

Understanding Radioactive Iodine Resistance in Thyroid Cancer: Overcoming Treatment Challenges

Radioactive Iodine Therapy: A Precision Weapon against Thyroid Cancer

Subscribe For Updates on Testing & Diagnostics

Sign up to receive updates from Qualisure regarding our latest developments in precision medicine tools.

First Name

Last Name

Email Address

Telephone

Organization

Country

I am a(n)

consent_sub

I consent to the use of my personal information for the purpose of receiving updates and communications about the latest developments in Precision Oncology.

Get Started

Thyroid GuidePx®

News

Investors